Cargando…

Does Prenatal Valproate Interact with a Genetic Reduction in the Serotonin Transporter? A Rat Study on Anxiety and Cognition

There is ample evidence that prenatal exposure to valproate (or valproic acid, VPA) enhances the risk of developing Autism Spectrum Disorders (ASD). In line with this, a single injection of VPA induces a multitude of ASD-like symptoms in animals, such as rats and mice. However, there is equally stro...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellenbroek, Bart A., August, Caren, Youn, Jiun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030776/
https://www.ncbi.nlm.nih.gov/pubmed/27708559
http://dx.doi.org/10.3389/fnins.2016.00424
_version_ 1782454737390534656
author Ellenbroek, Bart A.
August, Caren
Youn, Jiun
author_facet Ellenbroek, Bart A.
August, Caren
Youn, Jiun
author_sort Ellenbroek, Bart A.
collection PubMed
description There is ample evidence that prenatal exposure to valproate (or valproic acid, VPA) enhances the risk of developing Autism Spectrum Disorders (ASD). In line with this, a single injection of VPA induces a multitude of ASD-like symptoms in animals, such as rats and mice. However, there is equally strong evidence that genetic factors contribute significantly to the risk of ASD and indeed, like most other psychiatric disorders, ASD is now generally thought to results from an interaction between genetic and environmental factors. Given that VPA significantly impacts on the serotonergic system, and serotonin has strong biochemical and genetic links to ASD, we aimed to investigate the interaction between genetic reduction in the serotonin transporter and prenatal valproate administration. More specifically, we exposed both wildtype (SERT(+/+)) rats and rats heterozygous for the serotonin transporter deletion (SERT(+/−)) to a single injection of 400 mg/kg VPA at gestational day (GD) 12. The offspring, in adulthood, was assessed in four different tests: Elevated Plus Maze and Novelty Suppressed Feeding as measures for anxiety and prepulse inhibition (PPI) and latent inhibition as measures for cognition and information processing. The results show that prenatal VPA significantly increased anxiety in both paradigm, reduced PPI and reduced conditioning in the latent inhibition paradigm. However, we failed to find a significant gene–environment interaction. We propose that this may be related to the timing of the VPA injection and suggest that whereas GD12 might be optimal for affecting normal rat, rats with a genetically compromised serotonergic system may be more sensitive to VPA at earlier time points during gestation. Overall our data are the first to investigate gene (*) environmental interactions in a genetic rat model for ASD and suggest that timing may be of crucial importance to the long-term outcome.
format Online
Article
Text
id pubmed-5030776
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-50307762016-10-05 Does Prenatal Valproate Interact with a Genetic Reduction in the Serotonin Transporter? A Rat Study on Anxiety and Cognition Ellenbroek, Bart A. August, Caren Youn, Jiun Front Neurosci Neuroscience There is ample evidence that prenatal exposure to valproate (or valproic acid, VPA) enhances the risk of developing Autism Spectrum Disorders (ASD). In line with this, a single injection of VPA induces a multitude of ASD-like symptoms in animals, such as rats and mice. However, there is equally strong evidence that genetic factors contribute significantly to the risk of ASD and indeed, like most other psychiatric disorders, ASD is now generally thought to results from an interaction between genetic and environmental factors. Given that VPA significantly impacts on the serotonergic system, and serotonin has strong biochemical and genetic links to ASD, we aimed to investigate the interaction between genetic reduction in the serotonin transporter and prenatal valproate administration. More specifically, we exposed both wildtype (SERT(+/+)) rats and rats heterozygous for the serotonin transporter deletion (SERT(+/−)) to a single injection of 400 mg/kg VPA at gestational day (GD) 12. The offspring, in adulthood, was assessed in four different tests: Elevated Plus Maze and Novelty Suppressed Feeding as measures for anxiety and prepulse inhibition (PPI) and latent inhibition as measures for cognition and information processing. The results show that prenatal VPA significantly increased anxiety in both paradigm, reduced PPI and reduced conditioning in the latent inhibition paradigm. However, we failed to find a significant gene–environment interaction. We propose that this may be related to the timing of the VPA injection and suggest that whereas GD12 might be optimal for affecting normal rat, rats with a genetically compromised serotonergic system may be more sensitive to VPA at earlier time points during gestation. Overall our data are the first to investigate gene (*) environmental interactions in a genetic rat model for ASD and suggest that timing may be of crucial importance to the long-term outcome. Frontiers Media S.A. 2016-09-21 /pmc/articles/PMC5030776/ /pubmed/27708559 http://dx.doi.org/10.3389/fnins.2016.00424 Text en Copyright © 2016 Ellenbroek, August and Youn. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Ellenbroek, Bart A.
August, Caren
Youn, Jiun
Does Prenatal Valproate Interact with a Genetic Reduction in the Serotonin Transporter? A Rat Study on Anxiety and Cognition
title Does Prenatal Valproate Interact with a Genetic Reduction in the Serotonin Transporter? A Rat Study on Anxiety and Cognition
title_full Does Prenatal Valproate Interact with a Genetic Reduction in the Serotonin Transporter? A Rat Study on Anxiety and Cognition
title_fullStr Does Prenatal Valproate Interact with a Genetic Reduction in the Serotonin Transporter? A Rat Study on Anxiety and Cognition
title_full_unstemmed Does Prenatal Valproate Interact with a Genetic Reduction in the Serotonin Transporter? A Rat Study on Anxiety and Cognition
title_short Does Prenatal Valproate Interact with a Genetic Reduction in the Serotonin Transporter? A Rat Study on Anxiety and Cognition
title_sort does prenatal valproate interact with a genetic reduction in the serotonin transporter? a rat study on anxiety and cognition
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030776/
https://www.ncbi.nlm.nih.gov/pubmed/27708559
http://dx.doi.org/10.3389/fnins.2016.00424
work_keys_str_mv AT ellenbroekbarta doesprenatalvalproateinteractwithageneticreductionintheserotonintransporteraratstudyonanxietyandcognition
AT augustcaren doesprenatalvalproateinteractwithageneticreductionintheserotonintransporteraratstudyonanxietyandcognition
AT younjiun doesprenatalvalproateinteractwithageneticreductionintheserotonintransporteraratstudyonanxietyandcognition